Northern Trust
CABA icon

Northern Trust’s Cabaletta Bio CABA Stock Holding History

Northern Trust’s Portfolio CABA Stock Details CABA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.13M Buy
1,007,102
+768,660
+322% +$2.53M ﹤0.01% 2893
2026
Q1 		$641K Hold
238,442
– – ﹤0.01% 3511
2025
Q4 		$522K Buy
238,442
+11,455
+5% +$28.4K ﹤0.01% 3640
2025
Q3 		$531K Buy
226,987
+93,967
+71% +$161K ﹤0.01% 3628
2025
Q2 		$202K Sell
133,020
-266,746
-67% -$416K ﹤0.01% 3933
2025
Q1 		$554K Buy
399,766
+17,611
+5% +$37.5K ﹤0.01% 3535
2024
Q4 		$867K Sell
382,155
-5,849
-2% -$20.5K ﹤0.01% 3453
2024
Q3 		$1.83M Buy
388,004
+81,596
+27% +$472K ﹤0.01% 3056
2024
Q2 		$2.29M Buy
306,408
+2,247
+0.7% +$27.5K ﹤0.01% 2825
2024
Q1 		$5.19M Sell
304,161
-6,511
-2% -$140K ﹤0.01% 2428
2023
Q4 		$7.05M Buy
310,672
+10,903
+4% +$183K ﹤0.01% 2299
2023
Q3 		$4.56M Buy
299,769
+85,287
+40% +$1.17M ﹤0.01% 2500
2023
Q2 		$2.77M Buy
214,482
+174,335
+434% +$1.89M ﹤0.01% 2820
2023
Q1 		$332K Buy
40,147
+5,951
+17% +$55.7K ﹤0.01% 3619
2022
Q4 		$316K Buy
34,196
+4,889
+17% +$17.8K ﹤0.01% 3661
2022
Q3 		$19K Hold
29,307
– – ﹤0.01% 4554
2022
Q2 		$31K Hold
29,307
– – ﹤0.01% 4545
2022
Q1 		$59K Hold
29,307
– – ﹤0.01% 4498
2021
Q4 		$111K Buy
29,307
+4,337
+17% +$46.3K ﹤0.01% 4389
2021
Q3 		$304K Sell
24,970
-551
-2% -$5.08K ﹤0.01% 3972
2021
Q2 		$219K Sell
25,521
-104,647
-80% -$1.03M ﹤0.01% 4121
2021
Q1 		$1.45M Sell
130,168
-9,457
-7% -$116K ﹤0.01% 3419
2020
Q4 		$1.74M Sell
139,625
-5,074
-4% -$65.8K ﹤0.01% 3259
2020
Q3 		$1.57M Buy
144,699
+14,073
+11% +$162K ﹤0.01% 3172
2020
Q2 		$1.46M Buy
130,626
+33,191
+34% +$254K ﹤0.01% 3199
2020
Q1 		$712K Buy
97,435
+30,204
+45% +$414K ﹤0.01% 3349
2019
Q4 		$939K Buy
+67,231
New +$797K ﹤0.01% 3418

Other funds holding CABA

Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Northern Trust's CABA Position: Q2 2026 in Review

Northern Trust increased its Cabaletta Bio (CABA) stake by 322% in Q2 2026, buying an estimated $2.53M and bringing the position to 1,007,102 shares worth $3.13M. The position accounts for ﹤0.01% of the portfolio, ranked #2893.

Northern Trust first reported a position in CABA in Q4 2019 and has held it in 27 quarters since. The position peaked at $7.05M in Q4 2023. 86 funds tracked by Wall St. Rank hold CABA as of Q2 2026.

  • Northern Trust held 1,007,102 shares of Cabaletta Bio worth $3.13M as of Q2 2026.
  • Northern Trust bought 768,660 Cabaletta Bio shares in Q2 2026, an estimated $2.53M.
  • Cabaletta Bio made up ﹤0.01% of Northern Trust's portfolio in Q2 2026, its #2893 holding.
  • Northern Trust first reported a position in Cabaletta Bio in Q4 2019 and has held it in 27 quarters since.
  • Northern Trust's Cabaletta Bio position peaked at $7.05M in Q4 2023.
  • 86 funds tracked by Wall St. Rank held Cabaletta Bio as of Q2 2026.

Based on Northern Trust's 13F filing for Q2 2026, filed 13 Aug 2026.